News

News

Things change: schedules, labels, supply, and the evidence base. This desk tracks those changes and dates every entry.

Each item says what moved, when it moved, and where the claim comes from. Nothing here is breaking coverage. It is maintenance of the reference pages, published in the open.

Latest updates

Modafinil regulatory updates, 2026
Scheduling, prescribing restrictions and personal-import rules that moved this year, by jurisdiction.
Telehealth ADHD prescribing rules, 2026
Remote prescribing of controlled stimulants: where the rules stand and what changed after the flexibilities lapsed.
Adderall supply status, 2026
What the shortage notices actually say, which formulations are affected, and how to read a supply listing.
Cognitive enhancement research roundup, 2026
New trials and meta-analyses on wakefulness agents and cognition, and what each one can and cannot show.
Stimulant label changes to watch in 2026
Warnings, boxed-warning language and pregnancy sections that regulators have revised or opened for review.

Where updates land

Regulatory status by country

The table each regulatory item is folded back into.

Label change history

Dated record of warning and indication revisions.

Cognitive enhancement evidence

Where new trial results are summarised in context.